by Travis Johnson, Stock Gumshoe | June 2, 2014 11:09 pm
Biotech trading advisory/newsletter, designed to make shorter-term trades around “catalyst” events, mostly in drug development (previously called FDA[1] Trader when the publisher was still called Agora[2] Financial, Blanco took over after previous editor Paul Mampilly[3] left).
Source URL: https://www.stockgumshoe.com/reviews/fda-trader/
Copyright ©2024 Stock Gumshoe unless otherwise noted.